Hyperglycemia in patients admitted in intensive care units (ICU) with acute myocardial infarction is a common phenomena observed. This unique situation of cardiogenic insulin resistance does not spare neither diabetics nor non -diabetics. It is in addition to the inherent insulin resistance that is a part of diabetes mellatus, type 2 (DM2). It is brought about by various cytokines released from the damaged heart muscle. This cardiogenic insulin resistance has cardiac as well as systemic effects. The grave and independent risk role in post myocardial infarction (MI) and the complications, of the cardiac insulin resistance are highlighted. The concerted action of cardiologist and endocrinologist while in hospital is called for, so as to cover the grey areas between the two specialties, which otherwise falls into no man’s island. The systemic insulin resistance, once the patient is back in home setting, would test the patience of the physician, as usual doses of insulin just do not work! The article aims at creating awareness regarding concerted effects of all concerned to deliver holistic treatment to the patients.
A. S. V. Prasad
Department of Internal Medicine, G.I.T.A.M Dental College, Rushikonda, Visakhapatnam, Andhra Pradesh, India.
Read full article: http://bp.bookpi.org/index.php/bpi/catalog/view/40/158/298-1
View Volume: https://doi.org/10.9734/bpi/aast/v4